SYRA HEALTH CORP.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$3M
↓-24.6% -$906Kvs FY2024
Total Liabilities
$675K
↑+10.0% +$61Kvs FY2024
Equity
$2M
↓-27.1% -$780Kvs FY2024
Cash
$2M
↓-32.6% -$781Kvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $3M | $4M |
| Current Assets | $3M | $3M |
| Cash | $2M | $2M |
| ST Investments | $0 | $0 |
| Receivables | $918K | $681K |
| Inventory | $0 | $0 |
| Other Current | $205K | $277K |
| Non-Current Assets | $34K | $327K |
| PPE | $7K | $27K |
| Goodwill | $0 | $0 |
| Intangibles | $0 | $0 |
| Investments | $0 | $0 |
| Other Non-Current | $27K | $299K |
| Total Liab+Eq | $3M | $4M |
| Current Liab. | $675K | $614K |
| Accounts Payable | $0 | $102K |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $17K | $17K |
| Other CL | $658K | $495K |
| Non-Current Liab. | $0 | $187K |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $0 | $187K |
| Equity | $2M | $3M |
| Retained Earnings | $10M | $9M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · SYRA · Comparing FY2025 vs FY2024